In line with earlier studies, Liu et al. [60] reported that high SKP2 expression levels were observed in primary gastrointestinal stromal tumors (GISTs), and that these levels may pose an increased risk of disease progression. This evidence concerns the gene SKP2 and gastrointestinal stromal tumor.